Abstract Submission Criteria

Abstract notifications will commence Thursday 8 August 2019.

Abstract preparation requirements

Abstract submissions that do not conform will be excluded from consideration. Abstracts will ONLY be accepted via the online abstract submission portal.

Selection of oral and poster presentations is dependent on the content and presentation of the abstract.

All successful contributed paper and poster presenters must register and pay to attend the conference.

Rules for content and structure

  • Abstracts should describe work that has not previously been presented at a previous SHPA National Conference (publication or presentation of the work at another conference is not a criterion for exclusion).
  • Abstracts must be no more than 300 words in length, including headings but excluding the title.
  • The abstract title should be brief (no more than 15 words in length) and clearly state the nature of the work.
  • Author details (including institutions or affiliations) MUST NOT appear in the abstract.
  • No tables, graphs, pictures or diagrams are permitted in the abstract.
  • Abbreviations should be avoided where possible. Any abbreviations used should be spelled out in full on first use.
  • Statistical results should conform with the uniform requirements for manuscripts submitted to biomedical journals
  • References are not required but may be included. References should follow the reference citation guide

Submission categories

For MM2019, abstracts are welcomed for the following three categories. Each category has specific headings which must be used for the abstract.

Original research (includes Clinical Research, Drug Use Evaluations, Systematic Reviews and Meta-Analysis, Pharmacoeconomic Analysis, etc.)

Background: should briefly describe the rationale for the study.

Aim/Objective(s): a one sentence statement of the main study objective(s).

Methods: should include study design, methods, intervention.

Results: a summary of the main results including any relevant statistical analysis.

Conclusion(s): the main conclusion and interpretation of the results which are supported by the data provided.

Case reports

Objective: briefly describe the rationale for the case report.

Clinical Features: relevant demographic information, medical history, presenting problems and diagnoses.

Literature review: briefly examine current literature relating to or surrounding the case report.

Pharmacist Interventions, Case Progress and Outcomes: these may be presented together or separately and should detail the pharmacist’s role in the case.

Conclusion(s): outlining lessons learnt and/or implications/importance of the case report to pharmacy practitioners.

Pharmacy practice (includes Administration Projects, Health Professional Education, Medication Safety Initiatives, etc.)

Background: The background section should briefly describe background and rationale for service, program, problem, need, etc.

Description: The description section should describe the concept, service, role, or situation.

Action: The action section should describe the steps taken to identify and resolve a problem(s), implement change, or develop and implement the new program.

Evaluation: The evaluation should describe the evaluation process of the project and results of evaluation.

Implications: The implications section should describe the concept’s importance and usefulness to current and/or future practice.

Abstract submission information

All abstracts must be submitted electronically via the conference website.

  • You will be asked to enter the presenting author’s contact details, affiliation information, abstract title, proposed type of presentation (oral or poster), author(s), and brief biographical details of the presenting author.
  • If submitting more than one abstract, each abstract must be submitted under the name of the presenting author.
  • The presenting author is invited to indicate their preference for oral or poster presentation only (or either). However, the final decision is that of the scientific program committee and will be solely determined by the quality and suitability of the abstract.
  • Ensure all authors have reviewed the abstract(s) and agreed to its submission.
  • You will be asked to select up to three (3) specialty practice areas that relate to your abstract from the following list:
CardiologyClinical trials
Compounding servicesCritical care
Dispensing and distributionEducation and education visiting
Electronic medication managementEmergency medicine
General medicineGeriatric medicine
Infectious diseasesLeadership and management
Medication safetyMedicines information
Mental healthNephrology
NeurologyOncology and haematology
Paediatrics and neonatologyPain management
Palliative carePrimary care and transitions of care
RespiratoryRural and remote
Surgery and perioperative medicineWomen’s and newborn health